Wednesday Mar 24, 2021

The Gary Null Show - 03.24.21

Lion’s mane mushroom helps reduce depression and anxiety

Tohoku University (Japan), March 21, 2021

Several studies have shown the potential of lion’s mane mushroom to help address several health problems including those that are related to brain function.

Lion’s mane mushroom (Hericium erinaceus), also known as hedgehog mushroom, is a mushroom native to North America, Asia and Europe. Its fruiting bodies are said to contain polysaccharides that are beneficial to the human body.

This mushroom has a long history of medical uses, especially in Traditional Chinese Medicine (TCM) where it was used to help support brain health. In recent years, its value in supporting cognitive health has been supported by a number of studies.

The mushroom helps Reduce depression and anxiety

In a study published in the journal Biomedical Research, the mushroom was tested on female participants in order to tests its effects on mental health.

After taking lion’s mane mushroom cookies for four weeks, the participants reported reduced depression and anxiety. According to the researchers, this was due to two chemical constituents isolated from lion’s mane’s fruiting body called hericenones and erinacines. These two chemicals stimulate nerve growth factor (NGF) biosynthesis.

NGF takes part in a number of activities in the body that are essential in maintaining and organizing neurons. By stimulating NGF biosynthesis, lion’s mane is able to help improve mental health.

Meanwhile, in a study on mice, researchers from Tohoku University  in Japan discovered that lion’s mane mushroom may be used to prevent cognitive dysfunction.

The Japanese researchers administered 10 micrograms of amyloid-beta peptide to the mice on days seven and 14 in their 23-day experimental period. Also, the mice subjects were fed with food containing lion’s mane mushroom over the course of the experimental period.

To measure the results of their study, the team used Y-maze and the novel object recognition tests on the subjects. They discovered that the mushroom prevented the negative effects of amyloid-beta peptide on the spatial short-term and visual recognition memory of the mice. The study suggests that the mushroom might reverse even the effects of amyloid-beta peptide – a protein believed to cause Alzheimer’s disease.

Lion’s mane for cognitive impairment

Moreover, in another study conducted by Japanese scientists, lion’s mane mushroom showed potential in improving symptoms of mild cognitive impairment. This is the stage between aging-related cognitive decline and the development of dementia. Its symptoms include problems with memory, language, thinking or judgment.

The team took 30 patients with mild cognitive impairment and gave them 250mg tablets with 96 percent lion’s mane extract to be taken in four pieces for three times a day for 16 weeks. During weeks eight, 12 and 16, the patients underwent observation wherein they showed improvement in their cognitive function as displayed by the increase of their scores on the cognitive function scale. Moreover, the researchers conducted laboratory tests on the patients and saw that the intake of lion’s mane did not result in any side effect.

In addition, the patients’ scores in the cognitive function scale decreased by the time their intake of lion’s mane mushroom tablets stopped.

 

 

 

Quercetin-3-o-glucuronide alleviates cognitive deficit in mouse model of Alzheimer disease

Hua-zhong University of Science & Technology (China), March 22, 2021

 

According to news reporting from Wuhan, People’s Republic of China, research stated, “Scope Alzheimer’s disease (AD) is characterized by amyloid-beta (A beta) related imbalance, Tau-hyperphosphorylation, and neuroinflammation, in which A beta and neuroinflammation can induce brain insulin resistance (IR). Gut microbiome disorder is correlated with inflammation in AD.”

The news correspondents obtained a quote from the research from the Huazhong University of Science and Technology, “As of yet, there are no effective treatments clinically. Thus, it is focused on the potential benefit of quercetin-3-O-glucuronide (Q3G), a pharmacologically active flavonol glucuronide, on AD treatment by regulating brain IR and the gut microbiome. AD mice model built through intracerebroventricular injection of A beta(1-42) and AD cell model developed through the SH-SY5Y cell line and A beta(1-42) are used to explore the protective effects of Q3G on AD. Neurobehavioral test, brain insulin signaling pathway, and high-throughput pyrosequencing of 16S rRNA are assessed. Data show that Q3G attenuates neuroinflammation and brain IR in A beta(1-42)-injected mice and relieves apoptosis in A beta(1-42)-treated SH-SY5Y cells by interrupting the downstream insulin signaling. Q3G ameliorates A beta accumulation and Tau phosphorylation, restores CREB and BDNF levels in the hippocampus , and reverses A beta(1-42)-induced cognitive impairment. Besides, Q3G restores A beta(1-42)-induced reduction of short-chain fatty acids (SCFAs) and gut microbiota dysbiosis.”

According to the news reporters, the research concluded: “Q3G can alleviate brain IR through directly acting on the brain or modulating the gut-brain axis, ultimately to relieve A beta(1-42)-induced cognitive dysfunction.”

This research has been peer-reviewed.

 

 

Research shows possible link between number of fast-food outlets and heart attacks

Hunter Medical Research Institute & University of Newcastle (UK), March 17, 2021 

Researchers from the Hunter Medical Research Institute (HMRI), the University of Newcastle and Hunter New England Health (HNE Health) have found that for each new fast-food outlet the number of heart attacks per 100,000 people went up by four.

Published in the latest edition of the Internal Medicine Journal the study aimed to determine whether the number of fast-foodoutlets in an area could be considered an environmental risk factor for Myocardial Infarction (heart attack).

The team led by Dr. Tarunpreet Saluja from the University of Newcastle, compared all cases of Myocardial Infarction within the Hunter-New England Health District with the Fast-Food Outlet Density (FFD) of each Local Government Area within the district. 

"Heart attack is one of the leading causes of death worldwide" said Dr. Saluja, "However, recent data suggests that an increasing number of heart attacks cannot be explained by known risk factors."

"There is a well-established link between fast food consumption and cardiovascular diseases such as heart attack. This highlights the need to explore the role of food availability in the probability of having a heart attack."

The team found that FFD was positively correlated with an increase of myocardial infarction, even after accounting for other factors such as age, obesity, hyperlipidaemia (high cholesterol), hypertension (high blood pressure), smoking status, diabetes, and socioeconomic status. 

Study co-author and cardiologist at John Hunter Hospital, Professor Andrew Boyle said that while it has been known for some time that consuming fast food was bad for the heart no one had determined whether the number of stores was itself a predicting factor. 

"Until now there has been very little data on the link between fast-food outlet density and heart attacks, so these results should provide an important consideration for future public‐health policy and community development," said Professor Boyle. 

Study co-author and Associate Director of HMRI's Data Science Group, Dr. Christopher Oldmeadow, said that developing a new metric to calculate fast-food outlet density was key to the study and there was scope to expand the data to look at more outlets in the future. 

"For this study, we focused on the 10 most popular fast-food outlets in Australia and used census data to determine the density per 100,000 people in each local government area," Dr. Oldmeadow said. "This worked for the majority of the LGAs, but there is scope to investigate the relationship between smaller, locally operated fast‐food outlets and heart attacks."

 

Vitamin B6 may help calm cytokine storms in COVID-19

University of Hiroshima (Japan), March 14, 2021

Vitamin B6 may help calm cytokine storms and unclog blood clots linked to novel coronavirus (COVID-19) lethality, according to a new study published in the journal Frontiers in Nutrition.

In the paper, researchers from Hiroshima University pointed out growing evidence showing that vitamin B6 exerts a protective effect against chronic illnesses such as cardiovascular diseases and diabetes by suppressing inflammation, inflammasomes, oxidative stress, and carbonyl stress. Coronaviruses and influenza are among the viruses that can cause lethal lung injuries and death from acute respiratory distress syndrome worldwide. Viral infections evoke a “cytokine storm,” leading to lung capillary endothelial cell inflammation, neutrophil infiltration, and increased oxidative stress, the researchers said.

The researchers said thrombosis or blood clotting and cytokine storm or hyper-inflammation might be closely linked to the graveness of COVID-19. Cytokine storms happen when the immune system dangerously goes into overdrive and starts attacking even the healthy cells. Meanwhile, blood clots linked to COVID-19 can block capillaries, damaging vital organs like the heart, lungs, liver, and kidneys, according to the study.

Vitamin B6 is a known anti-thrombosis and anti-inflammation nutrient. Deficiency in this vitamin is also associated with lower immune function and higher susceptibility to viral infections.

Studies have so far explored the benefits of vitamins D and C and minerals like zinc and magnesium in fortifying immune response against COVID-19. Research on vitamin B6 has been limited, the researchers said. The researchers said they hope the paper will show vitamin B6's potential in lowering the odds of patients becoming seriously ill with the coronavirus, and prompt further research.

"It is of great interest to examine if vitamin B6 exerts protection against novel types of virus infection and pneumonia which will be encountered in the future,” said Thanutchaporn Kumrungsee, PhD, lead author of the paper, in a statement. “At present, there is few information regarding the protective role of nutrients against pneumonia and lung diseases.”

Vitamin B6 has a close relationship with the immune system, she said. Its levels always drop in people under chronic inflammation such as obesity, diabetes, and heart diseases.

“We can see from the news that obese and diabetic people are at high risk for COVID-19, said Kumrungsee. “Thus, our attempt in this paper is to shed light on the possible involvement of vitamin B6 in decreasing the severity of COVID-19.

 

 

Green space or light at night: How we can improve health

University of Adelaide (Australia), March 18, 2021

There is a growing body of evidence that exposure to green space is good for our health but a new study from the University of Adelaide has found that this may equally be due to how much light we are exposed to at night.

Spending time in green space can improve depressive symptoms, obesity, and sleep problems, and reduce the risk of breast and prostate cancer. Conversely, exposure to light at night, particularly urban light pollution, increases the risk of breast and prostate cancer, and can worsen depression, obesity and sleep problems. 

Researchers identified a negative correlation between green space diversity and outdoor artificial light at night for Australian major cities—in other words, the greener your environment, the less the light pollution, and vice versa. 

This makes intuitive sense, because the more developed an area is, the fewer trees there will be and the more lights there will be. 

Published in Environmental Research, the study questions whether the health benefits of green space exposure may in part be a result of avoiding light at night. 

"There seems to be a pattern here—yet, amazingly, no one has put these two things together—until now,"' said lead author Dr. Jessica Stanhope from the University of Adelaide's School of Allied Health Science and Practice. 

"It is possible that these factors have been confounding each other in epidemiological studies of the associations between residential green spaces and improved health, and urban outdoor artificial light at night exposure and poor health

"We have shown that green space is inversely associated with outdoor artificial light at night, making it unclear whether health outcomes result from the green space, the light at night, or possibly in an interaction of the two." 

Researchers recommend that epidemiological studies focus on resolving this problem as a priority, so that recommendations can be made for interventions that would improve the public health. For example, to improve population health, is it more important to plant green space in urban areas to give people in cities better green space exposure, or is it better to invest that effort in reducing urban light pollution, or both? 

"Some great studies have been done on the association between green space and health, which is a rapidly growing research area; and there are also very neat epidemiological studies of the adverse health effects of exposure to light at night," said Dr. Stanhope. 

"It is now really important that future studies include both factors so that we can better understand their association—only then can we make better public health recommendations about planning health-giving sustainable urban landscapes."

 

Supplements may protect those with low vitamin D levels from severe COVID-19

Albert Einstein College of Medicine, March 20, 2021

Patients with low vitamin D levels who are hospitalized for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.

"Given how common vitamin D deficiency is in the world and the United States, we believe that this research is highly relevant right now," said co-author Sweta Chekuri, M.D., of Montefiore Health System and Albert Einstein College of Medicine in the Bronx, New York. 

Research has shown that vitamin D supplementation can prevent inflammation in other respiratory diseases, but there have been limited studies examining the role of vitamin D supplementation in COVID-19. The purpose of the study was to determine whether being supplemented with vitamin D before being admitted to the hospital with COVID-19 resulted in less severe COVID-19 disease in patients with a low vitamin D level.

The researchers studied 124 adult patients with low vitamin D that was measured up to 90 days before their admission for COVID-19. They compared the patients who were supplemented with at least 1,000 units of vitamin D weekly to those who had not received vitamin D supplements in terms of whether they were mechanically ventilated or died during admission.

They found that patients who were supplemented were less likely to be mechanically ventilated or to die following admission, though the finding wasn't statistically significant (37.5 percent of patients who were not supplemented vs. 33.3 percent of those who were) They also found that more than half of those who should have been supplemented were not. 

"Though we weren't able to show a definitive link to severe COVID-19, it is clear that patients with low vitamin D should receive supplementation not only for bone health, but also for stronger protection against severe COVID-19," said co-author Corinne Levitus, D.O., of Montefiore Health System and Albert Einstein College of Medicine. "We hope this research will encourage clinicians to discuss adding this supplement with their patients who have low vitamin D, as this may reduce the odds of people developing severe COVID-19."

study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism last fall found over 80 percent of 200 COVID-19 patients in a hospital in Spain had vitamin D deficiency.

 

 

Study finds changes in gut microbiome connected to Alzheimer-like behavior

Oregon Health & Science University, March 19, 2021

New research in mice published in the journal Scientific Reports strengthens the growing scientific consensus regarding the role of the gut microbiome in neurodegenerative disorders including Alzheimer’s disease.

The study, led by researchers at Oregon Health & Science University, found a correlation between the composition of the gut microbiome and the behavioral and cognitive performance of mice carrying genes associated with Alzheimer’s. The mice carried the human amyloid precursor protein gene with dominant Alzheimer’s mutations generated by scientists in Japan.

The study further suggests a relationship between microbes in the digestive tract and the expression of genes that trigger Alzheimer-like symptoms in mice.

“You know the expression, ‘You are what you eat?’” said senior author Jacob Raber, Ph.D., professor of behavioral neuroscience in the OHSU School of Medicine. “This may be part of that. While all mice were fed the same diet, the gut microbiome is affected in a genotype-dependent fashion and this in turn might affect your brain.”

The findings are the first to demonstrate a direct connection between the gut microbiome and cognitive and behavioral changes in an Alzheimer’s disease animal model, and they are consistent with a recently published observational study in people newly diagnosed with Alzheimer’s. In fact, a U.S. clinical trial for the treatment of mild to moderate Alzheimer’s disease is currently underway involving a compound that targets microbes in the gut.

The research published breaks new ground.

In addition to the cognitive and behavioral changes that were measured, the study is the first to demonstrate a relationship between changes in the gut microbiome and epigenetic changes in neural tissue in the hippocampus, an area of the brain affected in Alzheimer’s. This type of research is not possible in people.

The microbiome is a complex assemblage of microorganisms such as bacteria that play a critical role in a wide range of functions in the body. In this case, researchers wanted to see if the gut microbiome affected cognitive and behavioral measures in specially bred mice at 6 months of age. So they compared wild-type mice with those genetically engineered to carry the human amyloid precursor protein gene with dominant Alzheimer’s mutations.

They found changes in the gut microbiome - measured in fecal pellets - corresponded with epigenetic regulation of the apolipoprotein E and Tomm40 genes, both associated with Alzheimer’s. They found a clear correlation, but they still can’t say whether one causes the other.

“Microbes may elicit an impact on behavioral and cognitive measures relevant to Alzheimer’s disease via epigenetic changes in the hippocampus,” Raber said. “Or, alternatively, it might be that the epigenetic changes in the hippocampus affect changes in the gut microbiome.”

The next phase of research will determine whether it’s possible to reduce Alzheimer’s-like symptoms in genetically predisposed mice by altering their diet.

“The exciting part of this is that you can manipulate the gut microbiome,” Raber said. “We can use probiotics and see what the effect is.”

Copyright © 2017 Progressive Radio Network. All rights reserved.

Podcast Powered By Podbean

Version: 20230822